nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Trauma—Mometasone—systemic scleroderma	0.0341	0.0341	CcSEcCtD
Finasteride—Prostatic disorder—Leflunomide—systemic scleroderma	0.0276	0.0276	CcSEcCtD
Finasteride—Prostatic disorder—Mycophenolic acid—systemic scleroderma	0.0264	0.0264	CcSEcCtD
Finasteride—Prostatic disorder—Mycophenolate mofetil—systemic scleroderma	0.0208	0.0208	CcSEcCtD
Finasteride—Swelling—Pentoxifylline—systemic scleroderma	0.0155	0.0155	CcSEcCtD
Finasteride—Neoplasm malignant—Azathioprine—systemic scleroderma	0.0146	0.0146	CcSEcCtD
Finasteride—Neoplasm malignant—Mycophenolic acid—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Finasteride—Injury—Mometasone—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Finasteride—Gynaecomastia—Captopril—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Finasteride—Trauma—Prednisone—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Finasteride—Neoplasm—Azathioprine—systemic scleroderma	0.0112	0.0112	CcSEcCtD
Finasteride—Neoplasm—Leflunomide—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Finasteride—Influenza—Mometasone—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Finasteride—Neoplasm—Mycophenolic acid—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Finasteride—Bronchitis—Mometasone—systemic scleroderma	0.00979	0.00979	CcSEcCtD
Finasteride—Orthostatic hypotension—Captopril—systemic scleroderma	0.00945	0.00945	CcSEcCtD
Finasteride—Swelling—Mycophenolic acid—systemic scleroderma	0.00922	0.00922	CcSEcCtD
Finasteride—Injury—Mycophenolic acid—systemic scleroderma	0.00885	0.00885	CcSEcCtD
Finasteride—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00853	0.00853	CcSEcCtD
Finasteride—Sinusitis—Mometasone—systemic scleroderma	0.00851	0.00851	CcSEcCtD
Finasteride—Erectile dysfunction—Captopril—systemic scleroderma	0.00823	0.00823	CcSEcCtD
Finasteride—Rhinitis—Mometasone—systemic scleroderma	0.00817	0.00817	CcSEcCtD
Finasteride—Pharyngitis—Mometasone—systemic scleroderma	0.00809	0.00809	CcSEcCtD
Finasteride—Neoplasm—Mycophenolate mofetil—systemic scleroderma	0.00799	0.00799	CcSEcCtD
Finasteride—Injury—Lisinopril—systemic scleroderma	0.00797	0.00797	CcSEcCtD
Finasteride—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.00791	0.00791	CcSEcCtD
Finasteride—Libido decreased—Lisinopril—systemic scleroderma	0.0079	0.0079	CcSEcCtD
Finasteride—Breast disorder—Leflunomide—systemic scleroderma	0.0077	0.0077	CcSEcCtD
Finasteride—Angioedema—Pentoxifylline—systemic scleroderma	0.00751	0.00751	CcSEcCtD
Finasteride—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00743	0.00743	CcSEcCtD
Finasteride—Influenza—Leflunomide—systemic scleroderma	0.00737	0.00737	CcSEcCtD
Finasteride—Immune system disorder—Mometasone—systemic scleroderma	0.00736	0.00736	CcSEcCtD
Finasteride—Breast disorder—Mycophenolic acid—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Lisinopril—systemic scleroderma	0.00727	0.00727	CcSEcCtD
Finasteride—Rhinitis—Captopril—systemic scleroderma	0.00717	0.00717	CcSEcCtD
Finasteride—Pharyngitis—Captopril—systemic scleroderma	0.0071	0.0071	CcSEcCtD
Finasteride—Bronchitis—Leflunomide—systemic scleroderma	0.00709	0.00709	CcSEcCtD
Finasteride—Influenza—Mycophenolic acid—systemic scleroderma	0.00703	0.00703	CcSEcCtD
Finasteride—Injury—Mycophenolate mofetil—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Finasteride—Bronchitis—Mycophenolic acid—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Finasteride—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00669	0.00669	CcSEcCtD
Finasteride—Infection—Pentoxifylline—systemic scleroderma	0.00666	0.00666	CcSEcCtD
Finasteride—Breast disorder—Lisinopril—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Finasteride—Angioedema—Mometasone—systemic scleroderma	0.00648	0.00648	CcSEcCtD
Finasteride—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00647	0.00647	CcSEcCtD
Finasteride—Influenza—Lisinopril—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Finasteride—Hypotension—Pentoxifylline—systemic scleroderma	0.00627	0.00627	CcSEcCtD
Finasteride—Sinusitis—Leflunomide—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Finasteride—Bronchitis—Lisinopril—systemic scleroderma	0.00609	0.00609	CcSEcCtD
Finasteride—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Finasteride—Somnolence—Pentoxifylline—systemic scleroderma	0.00596	0.00596	CcSEcCtD
Finasteride—Rhinitis—Leflunomide—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Finasteride—Sinusitis—Mycophenolic acid—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Finasteride—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00586	0.00586	CcSEcCtD
Finasteride—Pharyngitis—Leflunomide—systemic scleroderma	0.00585	0.00585	CcSEcCtD
Finasteride—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00583	0.00583	CcSEcCtD
Finasteride—Oedema peripheral—Leflunomide—systemic scleroderma	0.00581	0.00581	CcSEcCtD
Finasteride—Infection—Mometasone—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Finasteride—Angioedema—Captopril—systemic scleroderma	0.00569	0.00569	CcSEcCtD
Finasteride—Immune system disorder—Azathioprine—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Finasteride—Rhinitis—Mycophenolic acid—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Finasteride—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.00558	0.00558	CcSEcCtD
Finasteride—Influenza—Mycophenolate mofetil—systemic scleroderma	0.00555	0.00555	CcSEcCtD
Finasteride—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Finasteride—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Finasteride—Urticaria—Pentoxifylline—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Finasteride—Immune system disorder—Leflunomide—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Finasteride—Sinusitis—Lisinopril—systemic scleroderma	0.0053	0.0053	CcSEcCtD
Finasteride—Mental disorder—Leflunomide—systemic scleroderma	0.00517	0.00517	CcSEcCtD
Finasteride—Dyspnoea—Mometasone—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Finasteride—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Finasteride—Rhinitis—Lisinopril—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Finasteride—Pharyngitis—Lisinopril—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Finasteride—Oedema peripheral—Lisinopril—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Finasteride—Pain—Mometasone—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Finasteride—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Finasteride—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00493	0.00493	CcSEcCtD
Finasteride—Asthenia—Pentoxifylline—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Finasteride—Hypotension—Captopril—systemic scleroderma	0.00475	0.00475	CcSEcCtD
Finasteride—Pruritus—Pentoxifylline—systemic scleroderma	0.00475	0.00475	CcSEcCtD
Finasteride—Injury—Prednisone—systemic scleroderma	0.00473	0.00473	CcSEcCtD
Finasteride—Angioedema—Leflunomide—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Finasteride—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Finasteride—Dyspnoea—Captopril—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Finasteride—Neoplasm—Methotrexate—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Finasteride—Somnolence—Captopril—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Finasteride—Gynaecomastia—Methotrexate—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Finasteride—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Finasteride—Mental disorder—Lisinopril—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Finasteride—Dizziness—Pentoxifylline—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Finasteride—Infection—Azathioprine—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Finasteride—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Finasteride—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Finasteride—Rash—Pentoxifylline—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Finasteride—Dermatitis—Pentoxifylline—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Finasteride—Headache—Pentoxifylline—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Finasteride—Infection—Leflunomide—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Finasteride—Asthenia—Mometasone—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Finasteride—Hypotension—Azathioprine—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Finasteride—Pruritus—Mometasone—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Finasteride—Angioedema—Lisinopril—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Finasteride—Infection—Mycophenolic acid—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Finasteride—Hypotension—Leflunomide—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Finasteride—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Finasteride—Dyspnoea—Leflunomide—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Finasteride—Hypotension—Mycophenolic acid—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Finasteride—Rash—Mometasone—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Finasteride—Asthenia—Captopril—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Finasteride—Dermatitis—Mometasone—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Finasteride—Headache—Mometasone—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Finasteride—Pruritus—Captopril—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Finasteride—Pain—Leflunomide—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Finasteride—Infection—Lisinopril—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Finasteride—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Finasteride—Somnolence—Mycophenolic acid—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Finasteride—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Finasteride—Erectile dysfunction—Prednisone—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Finasteride—Pain—Mycophenolic acid—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Finasteride—Hypotension—Lisinopril—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Finasteride—Dizziness—Captopril—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Finasteride—Urticaria—Leflunomide—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Finasteride—Breast disorder—Methotrexate—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Finasteride—Hypersensitivity—Azathioprine—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Finasteride—Dyspnoea—Lisinopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Finasteride—Rash—Captopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Finasteride—Dermatitis—Captopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Finasteride—Somnolence—Lisinopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Finasteride—Headache—Captopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Finasteride—Infection—Mycophenolate mofetil—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Finasteride—Hypersensitivity—Leflunomide—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Finasteride—Pain—Lisinopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Finasteride—Asthenia—Leflunomide—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Finasteride—Pruritus—Leflunomide—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Finasteride—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Finasteride—Dizziness—Azathioprine—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Finasteride—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Finasteride—Asthenia—Mycophenolic acid—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Finasteride—Urticaria—Lisinopril—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Finasteride—Pruritus—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Finasteride—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Finasteride—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Finasteride—Rash—Azathioprine—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Finasteride—Dermatitis—Azathioprine—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Finasteride—Headache—Azathioprine—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Finasteride—Dizziness—Leflunomide—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Finasteride—Immune system disorder—Prednisone—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Finasteride—Pain—Mycophenolate mofetil—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Finasteride—Hypersensitivity—Lisinopril—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Finasteride—Dizziness—Mycophenolic acid—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Finasteride—Rash—Leflunomide—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Finasteride—Dermatitis—Leflunomide—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Finasteride—Mental disorder—Prednisone—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Finasteride—Headache—Leflunomide—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Finasteride—Asthenia—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Finasteride—Pruritus—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Finasteride—Rash—Mycophenolic acid—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Finasteride—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Finasteride—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Finasteride—Headache—Mycophenolic acid—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Finasteride—Pharyngitis—Methotrexate—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Finasteride—Angioedema—Prednisone—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Finasteride—Dizziness—Lisinopril—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Finasteride—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Finasteride—Immune system disorder—Methotrexate—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Finasteride—Rash—Lisinopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Finasteride—Dermatitis—Lisinopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Finasteride—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Finasteride—Headache—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Finasteride—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Finasteride—Mental disorder—Methotrexate—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Finasteride—Infection—Prednisone—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Finasteride—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Finasteride—Rash—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Finasteride—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Finasteride—Headache—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Finasteride—Infection—Methotrexate—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Finasteride—Urticaria—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Finasteride—Hypotension—Methotrexate—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Finasteride—Dyspnoea—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Finasteride—Somnolence—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Finasteride—Hypersensitivity—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Finasteride—Asthenia—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Finasteride—Pain—Methotrexate—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Finasteride—Pruritus—Prednisone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Finasteride—Urticaria—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Finasteride—Dizziness—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Finasteride—Rash—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Finasteride—Dermatitis—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Finasteride—Headache—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Finasteride—Hypersensitivity—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Finasteride—Asthenia—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Finasteride—Pruritus—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Finasteride—Dizziness—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Finasteride—Rash—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Finasteride—Dermatitis—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Finasteride—Headache—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
